The results of this study provide the evidences that ( @ ) the calcineurin inhibitor ( CNI ) minimization by the introduction of everolimus after @-month posttransplantation keeps the incidences of acute rejection and additional risks as low as the conventional immunosuppression ; ( @ ) it allows minimizing CNI exposure , consequently reducing CNI nephrotoxicity and preserving renal function .